| Chaithra B Nagar, MD | |
|
3 Harbor Drive, Suite 111, Sausalito, CA 94965 | |
| (415) 683-2988 | |
| (415) 683-2980 |
| Full Name | Chaithra B Nagar |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 3 Harbor Drive, Sausalito, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073589222 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A88752 (California) | Primary |
| Entity Name | University Of California Sfgh Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366417420 PECOS PAC ID: 5496668410 Enrollment ID: O20031112000551 |
News Archive
Emergent BioSolutions Inc. today announced the initiation of a Phase 2 study (protocol 16201) of TRU-016 in combination with bendamustine for patients with relapsed chronic lymphocytic leukemia (CLL).
Researchers from the Department of Preventive Medicine and Public Health from the University of Granada have carried out a study with patients over 60.
A research group at Lund University in Sweden has found a new way to identify the most malignant tumours in children. The method involves studying genetic 'micro-variation', rather than the presence of individual mutations.
The National Institutes of Health has awarded grants to researchers in the Perelman School of Medicine at the University of Pennsylvania to support "highly innovative and broadly impactful" biomedical science through the NIH Common Fund's High-Risk, High-Reward Research program. The seven awards total approximately $8.2 million over five years,
Northwestern Medicine scientists have discovered that a subset of immune cells called nonclassical monocytes (NCMs), previously unknown to reside in the lungs, play a key role in driving primary graft dysfunction (PGD), the leading cause of death after lung transplantation.
› Verified 4 days ago
| Entity Name | University Of California San Francisco |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861578973 PECOS PAC ID: 4486567229 Enrollment ID: O20031212000897 |
News Archive
Emergent BioSolutions Inc. today announced the initiation of a Phase 2 study (protocol 16201) of TRU-016 in combination with bendamustine for patients with relapsed chronic lymphocytic leukemia (CLL).
Researchers from the Department of Preventive Medicine and Public Health from the University of Granada have carried out a study with patients over 60.
A research group at Lund University in Sweden has found a new way to identify the most malignant tumours in children. The method involves studying genetic 'micro-variation', rather than the presence of individual mutations.
The National Institutes of Health has awarded grants to researchers in the Perelman School of Medicine at the University of Pennsylvania to support "highly innovative and broadly impactful" biomedical science through the NIH Common Fund's High-Risk, High-Reward Research program. The seven awards total approximately $8.2 million over five years,
Northwestern Medicine scientists have discovered that a subset of immune cells called nonclassical monocytes (NCMs), previously unknown to reside in the lungs, play a key role in driving primary graft dysfunction (PGD), the leading cause of death after lung transplantation.
› Verified 4 days ago
| Entity Name | Ucsf Medical Group Business Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477624104 PECOS PAC ID: 3779497870 Enrollment ID: O20040622001513 |
News Archive
Emergent BioSolutions Inc. today announced the initiation of a Phase 2 study (protocol 16201) of TRU-016 in combination with bendamustine for patients with relapsed chronic lymphocytic leukemia (CLL).
Researchers from the Department of Preventive Medicine and Public Health from the University of Granada have carried out a study with patients over 60.
A research group at Lund University in Sweden has found a new way to identify the most malignant tumours in children. The method involves studying genetic 'micro-variation', rather than the presence of individual mutations.
The National Institutes of Health has awarded grants to researchers in the Perelman School of Medicine at the University of Pennsylvania to support "highly innovative and broadly impactful" biomedical science through the NIH Common Fund's High-Risk, High-Reward Research program. The seven awards total approximately $8.2 million over five years,
Northwestern Medicine scientists have discovered that a subset of immune cells called nonclassical monocytes (NCMs), previously unknown to reside in the lungs, play a key role in driving primary graft dysfunction (PGD), the leading cause of death after lung transplantation.
› Verified 4 days ago
| Entity Name | City & County Of San Francisco |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982737524 PECOS PAC ID: 1658280748 Enrollment ID: O20050309000770 |
News Archive
Emergent BioSolutions Inc. today announced the initiation of a Phase 2 study (protocol 16201) of TRU-016 in combination with bendamustine for patients with relapsed chronic lymphocytic leukemia (CLL).
Researchers from the Department of Preventive Medicine and Public Health from the University of Granada have carried out a study with patients over 60.
A research group at Lund University in Sweden has found a new way to identify the most malignant tumours in children. The method involves studying genetic 'micro-variation', rather than the presence of individual mutations.
The National Institutes of Health has awarded grants to researchers in the Perelman School of Medicine at the University of Pennsylvania to support "highly innovative and broadly impactful" biomedical science through the NIH Common Fund's High-Risk, High-Reward Research program. The seven awards total approximately $8.2 million over five years,
Northwestern Medicine scientists have discovered that a subset of immune cells called nonclassical monocytes (NCMs), previously unknown to reside in the lungs, play a key role in driving primary graft dysfunction (PGD), the leading cause of death after lung transplantation.
› Verified 4 days ago
| Entity Name | Regents Univ Of California Ucsf |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124439807 PECOS PAC ID: 6305160300 Enrollment ID: O20150122001375 |
News Archive
Emergent BioSolutions Inc. today announced the initiation of a Phase 2 study (protocol 16201) of TRU-016 in combination with bendamustine for patients with relapsed chronic lymphocytic leukemia (CLL).
Researchers from the Department of Preventive Medicine and Public Health from the University of Granada have carried out a study with patients over 60.
A research group at Lund University in Sweden has found a new way to identify the most malignant tumours in children. The method involves studying genetic 'micro-variation', rather than the presence of individual mutations.
The National Institutes of Health has awarded grants to researchers in the Perelman School of Medicine at the University of Pennsylvania to support "highly innovative and broadly impactful" biomedical science through the NIH Common Fund's High-Risk, High-Reward Research program. The seven awards total approximately $8.2 million over five years,
Northwestern Medicine scientists have discovered that a subset of immune cells called nonclassical monocytes (NCMs), previously unknown to reside in the lungs, play a key role in driving primary graft dysfunction (PGD), the leading cause of death after lung transplantation.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Chaithra B Nagar, MD 3 Harbor Drive, Suite 111, Sausalito, CA 94965 Ph: (415) 683-2988 | Chaithra B Nagar, MD 3 Harbor Drive, Suite 111, Sausalito, CA 94965 Ph: (415) 683-2988 |
News Archive
Emergent BioSolutions Inc. today announced the initiation of a Phase 2 study (protocol 16201) of TRU-016 in combination with bendamustine for patients with relapsed chronic lymphocytic leukemia (CLL).
Researchers from the Department of Preventive Medicine and Public Health from the University of Granada have carried out a study with patients over 60.
A research group at Lund University in Sweden has found a new way to identify the most malignant tumours in children. The method involves studying genetic 'micro-variation', rather than the presence of individual mutations.
The National Institutes of Health has awarded grants to researchers in the Perelman School of Medicine at the University of Pennsylvania to support "highly innovative and broadly impactful" biomedical science through the NIH Common Fund's High-Risk, High-Reward Research program. The seven awards total approximately $8.2 million over five years,
Northwestern Medicine scientists have discovered that a subset of immune cells called nonclassical monocytes (NCMs), previously unknown to reside in the lungs, play a key role in driving primary graft dysfunction (PGD), the leading cause of death after lung transplantation.
› Verified 4 days ago
Dr. Matthew Edward Naythons, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 180 Harbor Dr, Suite 101, Sausalito, CA 94965 Phone: 415-332-0808 | |
Dr. Edward Fotsch, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2 Alexander Ave, Sausalito, CA 94965 Phone: 415-332-8599 Fax: 415-332-8530 | |
Rachel Alt, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 6 Cypress Pl, Sausalito, CA 94965 Phone: 347-753-4057 | |
Nadine Aldahhan, DO Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 3 Harbor Dr Ste 111, Sausalito, CA 94965 Phone: 415-683-2988 Fax: 415-683-2900 |